Evidence-based medicine in the field of plastic surgery is evolving to address the specific needs of a patient demographic redefined by blockbuster weight-loss drugs. The widespread adoption of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and tirzepatide, has created a
Santa Clara County can only graduate from external monitoring if it exceeds the new healthcare targets by ten percentage points for an entire calendar year. This stringent requirement highlights the gravity of the current situation within the local jail system, where years of legal maneuvering have
Health economics data suggests that reducing the frequency of blood transfusions can help compress the high costs associated with secondary organ damage and chelation therapy. The recent FDA approval of mitapivat, now available as AQVESME, represents the most significant breakthrough in the
Before a patient even enters the room, Tandem Health’s AI synthesizes complex medical histories into concise summaries to streamline the clinical consultation process. This innovative approach has paved the way for the Stockholm-based company to secure a landmark $100 million Series B funding
Prospective trials must be specifically designed to capture failure modes and edge-case behaviors rather than simply replicating success rates in controlled environments. As we navigate the complex landscape of 2026, the healthcare sector is increasingly saturated with Large Language Models that
Many patients are now seeking direct access to supplemental screenings at specialized clinics to bypass the logistical hurdles of traditional referrals. This shift reflects a growing awareness that while mammography has long served as the primary defense against breast cancer, it may not be a
